Prestige Consumer Healthcare Inc.
Related Competitor Intelligence
Compare market positioning with top industry peers
Explore Prestige Consumer Healthcare
Core profile pages, annual revenue records, and related research hubs for this company.
Prestige Consumer Healthcare Inc.
Compare market positioning with top industry peers
Explore Prestige Consumer Healthcare
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$1.09B
Market Cap
$4.1B
Net Income
$190M
Employees
1,100
Prestige Consumer Healthcare is functioning as a focused, lean operator of self-care OTC brands with a return on equity. Under CEO Ron Lombardi, the consumer healthcare company generated exactly $1.2 billion in revenue and maintains a $4.1 billion market cap with exactly 1100 employees. The financial narrative in 2026 is entirely defined by disciplined brand stewardship; avoiding commoditized price wars, Prestige extracts lucrative margins by defending entrenched niche brands (Clear Eyes, Monistat, BC Headache Powder) that command shelf loyalty with minimal advertising investment.
Revenue Trend Analysis
YoY Change
-4.3%
2-Year CAGR
-1.6%
Peak Year
2025
Trend
Mostly Growing
Prestige Consumer Healthcare Inc. has reported revenue across 3 fiscal years, compounding at -1.6% annually over 2 years. The most recent year saw a 4.3% decline versus the prior year. Revenue peaked in 2025 at $1.1B. Out of 2 reported periods, 1 showed growth and 1 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2026 | $1.1B | $190M | -4.3% |
| FY2025 | $1.1B | $215M | +1.1% |
| FY2024 | $1.1B | $209M | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Prestige Consumer Healthcare Inc. reported approximately $1.2B in fiscal year 2026 with a team of 1,100 employees worldwide.
Prestige Consumer Healthcare Inc. strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.
Financial performance in Over-the-Counter Consumer Healthcare is driven by steady cash generation and pricing power, enabling Prestige Consumer Healthcare Inc. to reinvest in high-return strategic initiatives.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Prestige Consumer Healthcare Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/prestige-consumer/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Prestige Consumer Healthcare Inc. reported $1B in revenue (FY2026).</strong><br>Source: <a href="https://corpdigest.com/company/prestige-consumer/financials" target="_blank" rel="noopener">CorpDigest — Prestige Consumer Healthcare Inc. financials</a></div>